GlassScriptPhysician profile
Ramesh Bhoothapuri
NPI 1124021076
$670.08
in general payments reported to CMS, 2019-2025
9 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $116 · 2023: $235 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $484 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.38 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calliditas Therapeutics US INC. | $146.41 | 2023-2025 | Tarpeyo |
| Bayer Healthcare Pharmaceuticals INC. | $120.07 | 2023 | |
| Sanofi-Aventis U.S. LLC | $110.00 | 2025 | |
| Veloxis Pharmaceuticals, INC. | $95.63 | 2022 | |
| Mallinckrodt Hospital Products INC. | $69.99 | 2025 | Acthar |
| Vantive US Healthcare LLC | $50.95 | 2025 | Renal - Chronic |
| Ardelyx, INC. | $31.66 | 2025 | Ibsrela |
| Travere Therapeutics, INC. | $25.29 | 2025 | |
| Amgen INC. | $20.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramesh Bhoothapuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.